• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

What to call someone who uses heroin?

Bioengineer by Bioengineer
July 16, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

First-ever study to ask people who use heroin what they want to be called finds ‘people first’ language often best, and language suggesting misuse or dependence generally worst

First-ever study to ask people who use heroin what they want to be called finds “people first” language often best, and language suggesting misuse or dependence generally worst.

In the ongoing opioid crisis, many researchers and clinicians now use “person first” terms such as “person with substance use disorder” instead of loaded labels like “addict,” but little research has focused on the language preferences of this population. Now, a first-of-its-kind study by researchers from the Boston University School of Public Health (BUSPH) and the University of Massachusetts Medical School (UMMS), published in the journal Addiction, has found that people entering treatment for heroin use most often called themselves “addicts,” but preferred that others called them “people who use drugs.”

“In the end, researchers, clinicians, and families should not automatically use the same terms that people who use heroin call themselves, but instead ask about preferences,” says senior study author Dr. Michael Stein, professor and chair of health law, policy & management at BUSPH. “Of course, most people just want to be called by their name.”

The researchers surveyed 263 people undergoing in-patient evaluation and withdrawal symptom management at the Stanley Street Treatment and Resources program (SSTAR) in Fall River, Massachusetts. The terms that the most respondents never wanted to be called were “heroin misuser” and “heroin-dependent,” and most did not like slang terms such as “junkie.”

“Persons who use heroin often complain about interactions with healthcare providers, due at least in part to the unfortunate language providers use–which is taken, sometimes rightly, as a sign of disrespect,” Stein says. “Such antagonism can’t be good for clinical outcomes.”

“We hope this research will inform future work centering on the perspectives of individuals who use drugs, and begin to establish connections between the language that individuals use to describe themselves and treatment engagement,” says the study’s lead author, Dr. Ekaterina Pivovarova, assistant professor of psychiatry at UMMS and faculty in the Massachusetts Center of Excellence for Specialty Courts.

###

About the Boston University School of Public Health

Founded in 1976, the Boston University School of Public Health is one of the top five ranked private schools of public health in the world. It offers master’s- and doctoral-level education in public health. The faculty in six departments conduct policy-changing public health research around the world, with the mission of improving the health of populations–especially the disadvantaged, underserved, and vulnerable–locally and globally.

Contact:

Michelle Samuels, 617-358-3370, [email protected]

Michael Stein: [email protected]

Ekaterina Pivovarova: [email protected]

Media Contact
Michelle Samuels
[email protected]
http://dx.doi.org/10.1111/add.14699

Tags: AddictionMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Curcuma longa’s Potent Action Against Trichophyton spp.

September 1, 2025

ISRIB: Targeting Ferroptosis in Septic Heart Dysfunction

September 1, 2025

Boosting Rheumatoid Arthritis X-ray Analysis with Attention

September 1, 2025

Evaluating Outcomes of Tianjin Eye Hospital Project

September 1, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Curcuma longa’s Potent Action Against Trichophyton spp.

ISRIB: Targeting Ferroptosis in Septic Heart Dysfunction

Boosting Rheumatoid Arthritis X-ray Analysis with Attention

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.